Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)

CUSIP: 03168L105

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Class A Common Stock, par value $0.01
Shares outstanding
315,976,000
Total 13F shares
100,743,592
Share change
-37,981
Total reported value
$481,044,810
Put/Call ratio
106%
Price per share
$4.79
Number of holders
148
Value change
-$750,941
Number of buys
55
Number of sells
68

Quarterly Holders Quick Answers

What is CUSIP 03168L105?
CUSIP 03168L105 identifies AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q4 2021

As of 31 Dec 2021, Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) was held by 148 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 100,743,592 shares. The largest 10 holders included Fosun International Ltd, TPG GP A, LLC, VANGUARD GROUP INC, BlackRock Inc., Eversept Partners, LP, Point72 Asset Management, L.P., Neuberger Berman Group LLC, STATE STREET CORP, Nuveen Asset Management, LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 148 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.